Literature DB >> 21268130

Activation and up-regulation of translation initiation factor 4B contribute to arsenic-induced transformation.

Yong Zhang1, Qing Wang, Xiaoling Guo, Robert Miller, Yinglu Guo, Hsin-Sheng Yang.   

Abstract

Arsenic is a known human carcinogen. However, the mechanism of how arsenic induces cell transformation remains unclear. In this study, we demonstrated that long-term exposure to sodium arsenite at low-dose (2 µM) increases cell proliferation and neoplastic transformation in a mouse epidermal cell model, JB6 promotion-susceptible cells. The phosphorylation of AKT and its downstream targets, 70-kDa ribosomal protein S6 kinase (p70S6K) and translation initiation factor 4B (eIF4B), are increased in the arsenite treated cells, indicating that long-term arsenite treatment activates AKT-p70S6K signaling pathway. In addition, long-term exposure to arsenite up-regulates eIF4B expression and increases the rate of translation. Knockdown of eIF4B expression resulted in inhibition of arsenic-induced cell proliferation, transformation, and translation. Moreover, the expression of c-Myc which is up-regulated by long-term arsenite treatment is inhibited by eIF4B knockdown. Taken together, these results indicate that activation and up-regulation of eIF4B contributes to arsenic-induced transformation in JB6 cells.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21268130      PMCID: PMC3110507          DOI: 10.1002/mc.20733

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  38 in total

1.  Tumor promoter produces anchorage independence in mouse epidermal cells by an induction mechanism.

Authors:  N H Colburn
Journal:  Carcinogenesis       Date:  1980       Impact factor: 4.944

2.  Tumor promoter arsenite stimulates histone H3 phosphoacetylation of proto-oncogenes c-fos and c-jun chromatin in human diploid fibroblasts.

Authors:  Ji Li; Myriam Gorospe; Janice Barnes; Yusen Liu
Journal:  J Biol Chem       Date:  2003-01-23       Impact factor: 5.157

3.  Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation.

Authors:  Hsin-Sheng Yang; Jennifer L Knies; Cristi Stark; Nancy H Colburn
Journal:  Oncogene       Date:  2003-06-12       Impact factor: 9.867

4.  Inorganic arsenite-induced malignant transformation of human prostate epithelial cells.

Authors:  William E Achanzar; Eduardo M Brambila; Bhalchandra A Diwan; Mukta M Webber; Michael P Waalkes
Journal:  J Natl Cancer Inst       Date:  2002-12-18       Impact factor: 13.506

5.  The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation.

Authors:  Hsin-Sheng Yang; Aaron P Jansen; Anton A Komar; Xiaojing Zheng; William C Merrick; Sylvain Costes; Stephen J Lockett; Nahum Sonenberg; Nancy H Colburn
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

6.  Genetic events associated with arsenic-induced malignant transformation: applications of cDNA microarray technology.

Authors:  H Chen; J Liu; B A Merrick; M P Waalkes
Journal:  Mol Carcinog       Date:  2001-02       Impact factor: 4.784

7.  Expression of the translation initiation factor eIF4E in the polyp-cancer sequence in the colon.

Authors:  H J Berkel; E A Turbat-Herrera; R Shi; A de Benedetti
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-06       Impact factor: 4.254

8.  K6/ODC transgenic mice as a sensitive model for carcinogen identification.

Authors:  Y Chen; L C Megosh; S K Gilmour; J A Sawicki; T G O'Brien
Journal:  Toxicol Lett       Date:  2000-07-27       Impact factor: 4.372

9.  Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.

Authors:  H Chen; J Liu; C Q Zhao; B A Diwan; B A Merrick; M P Waalkes
Journal:  Toxicol Appl Pharmacol       Date:  2001-09-15       Impact factor: 4.219

10.  A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation.

Authors:  H S Yang; A P Jansen; R Nair; K Shibahara; A K Verma; J L Cmarik; N H Colburn
Journal:  Oncogene       Date:  2001-02-08       Impact factor: 9.867

View more
  5 in total

1.  AKT Activation by Pdcd4 Knockdown Up-Regulates Cyclin D1 Expression and Promotes Cell Proliferation.

Authors:  Xiaoling Guo; Wenjuan Li; Qing Wang; Hsin-Sheng Yang
Journal:  Genes Cancer       Date:  2011-08

2.  Down-regulation of programmed cell death 4 leads to epithelial to mesenchymal transition and promotes metastasis in mice.

Authors:  Qing Wang; Jiang Zhu; Yong Zhang; Zhenxiao Sun; Xiaoling Guo; Xin Wang; Eun Lee; Vasudevan Bakthavatchalu; Qifeng Yang; Hsin-Sheng Yang
Journal:  Eur J Cancer       Date:  2013-01-10       Impact factor: 9.162

3.  Effects of arsenic sulfide (As2S2) on B and T lymphoma cell lines and possible underlying mechanisms.

Authors:  Xianglu Li; Xinyu Liu; Ling Wang; Xiao Lv; Peipei Li; Kang Lu; Xin Wang
Journal:  Biomed Rep       Date:  2013-05-30

4.  Akt activation is responsible for enhanced migratory and invasive behavior of arsenic-transformed human bronchial epithelial cells.

Authors:  Zhishan Wang; Junling Yang; Theresa Fisher; Hua Xiao; Yiguo Jiang; Chengfeng Yang
Journal:  Environ Health Perspect       Date:  2011-09-27       Impact factor: 9.031

5.  Phosphoproteomic Analysis of KSHV-Infected Cells Reveals Roles of ORF45-Activated RSK during Lytic Replication.

Authors:  Denis Avey; Sarah Tepper; Wenwei Li; Zachary Turpin; Fanxiu Zhu
Journal:  PLoS Pathog       Date:  2015-07-02       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.